These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3255162)

  • 1. [In vitro activity of mezlocillin and azlocillin on hospital bacterial strains].
    Rusu V; Dorobăţ O
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(4):347-56. PubMed ID: 3255162
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of in vitro susceptibilities among gram-negative rods.
    Westblom TU; Midkiff BR
    W V Med J; 1989 Jul; 85(7):279-80. PubMed ID: 2756707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro susceptibility of gram-negative bacteria isolated from urinary tract infections to acylureidopenicillins].
    Cerikcioğlu N; Ustaçelebi S; Günalp A
    Mikrobiyol Bul; 1986 Jul; 20(3):139-44. PubMed ID: 3561279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of mezlocillin against gram-negative and gram-positive bacteria from clinical isolates].
    Ravizzola G; Foresti I; Minelli F
    G Ital Chemioter; 1985; 32(2):277-80. PubMed ID: 3833562
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro antibacterial activity of imipenem and other agents against gram-negative and gram-positive strains isolated from clinical specimens.
    Bartoloni A; Colao MG; Giganti E; Orsi A; Aquilini D; Corti G; Paradisi F
    G Ital Chemioter; 1988; 35(1-3):1-5. PubMed ID: 3256508
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro activity of azlocillin and mezlocillin].
    Naumann G; Fölsch W; Straube E; Schmidt H
    Z Gesamte Hyg; 1984 Aug; 30(8):427-31. PubMed ID: 6485412
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro combination effects of cefotetan with four aminoglycosides, piperacillin and mezlocillin on gram-positive and gram-negative nosocomial bacteria.
    Just HM; Becker C; Bassler M; Daschner FD
    Chemotherapy; 1984; 30(6):387-91. PubMed ID: 6596165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microorganisms isolated in 54 patients receiving bone marrow transplants and evaluation of their sensitivity to antimicrobial agents].
    Valls A; Grañena A; Carreras E; Almela M; Jiménez de Anta MT; Marín P; Rozman C
    Med Clin (Barc); 1987 Nov; 89(18):768-72. PubMed ID: 3323696
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the etiological structure and dynamics of antibiotic resistance in the causative agents of suppurative inflammatory diseases in the patients at a large general hospital].
    Kuznetsova SM; Samoĭlova LN; Speranskaia ON; Abadzhieva AN; Fomina IP
    Antibiotiki; 1984 Aug; 29(8):605-13. PubMed ID: 6486756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of netilmicin alone and in combination with azlocillin, mezlocillin and imipenem against 149 coagulase-negative staphylococci.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; D'Eletto MR; D'Antonio D; Ravagnan G
    Drugs Exp Clin Res; 1989; 15(6-7):303-8. PubMed ID: 2591301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term care units--nest of resistant bacteria?].
    Laine J; Lumio J
    Duodecim; 2005; 121(15):1679-81. PubMed ID: 16211842
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of ceftizoxime against gram-positive strains isolated in a hospital environment].
    Grassi L; Maderna P
    G Ital Chemioter; 1988; 35(1-3):11-5. PubMed ID: 3256509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Patterns of susceptibility to 19 antibiotics of bacteria isolated from blood cultures in a reference hospital in Mexico City].
    Giraud MC; Calva JJ; Huazano F; Ponce de León S; Ruiz-Palacios G
    Rev Invest Clin; 1986; 38(1):7-14. PubMed ID: 3738270
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern of bacterial infections and antimicrobial susceptibility at the Kenyatta National Hospital, Nairobi, Kenya.
    Omari MA; Malonza IM; Bwayo JJ; Mutere AN; Murage EM; Mwatha AK; Ndinya-Achola JO
    East Afr Med J; 1997 Mar; 74(3):134-7. PubMed ID: 9185406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the antibacterial activity of two new acylureidopenicillins, mezlocillin and azlocillin.
    Soares LA; Trabulsi LR
    Arzneimittelforschung; 1979; 29(12a):1932-4. PubMed ID: 543893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 18. First point prevalence survey of nosocomial infections in the intensive care units of a tertiary care hospital in Albania.
    Faria S; Sodano L; Dauri M; Sabato AF; Gjata A; Kito I; Llazo E; Bilaj A; Mertiraj O; Schinaia N;
    J Hosp Infect; 2008 May; 69(1):95-7. PubMed ID: 18346815
    [No Abstract]   [Full Text] [Related]  

  • 19. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S; Marchese A; Debbia EA
    Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
    Cuffini AM; Tullio V; Vaiani G; Carlone NA
    J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.